November 1, 2010

Cinacalcet hydrochloride treatment significantly improves all-cause and cardiovascular survival in a large cohort of hemodialysis patients

.   .   

This observational study utilizing USRDS data showed a survival benefit associated with the use of cinacalcet in those patients receiving intravenous vitamin D.  The authors indicate that “definitive proof, however, of a survival advantage awaits the performance of randomized clinical trials.”

Related Articles:

Bone Mineral Metabolism